Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT(TM) Non-Invasive, Daily-Wear Adhesive Glucose Monitor

Stock Information for Nemaura Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nemaura Medical Inc.

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
Important Update on Listing Status and Strategic Direction
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.